Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma

17 Mar 2006

1

Aurobindo Pharma Ltd has been given the license to market Stavudine and Didanosine, two important anti retro virals by Bristol-Myers Squibb Company. The license covers 49 countries including South Africa.

One of the objectives of this license is to increase access of the products for the benefit of the people in the aforesaid territory specifically for the treatment of HIV / AIDS.

Aurobindo Pharma has the largest number of approved products by US FDA for the ARV segment and anchors the management of AIDS by supplying APIs and formulations for most of the anti retro virals.

Stavudine Capsules 30mg and 40mg and Stavudine Oral Solution 1mg / ml are already approved by the US FDA under PEPFAR programme. The US FDA already approves the relevant API and formulation facilities.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers